Navigation Links
Boston Scientific Resolves Outstanding Litigation Matter, Finalizes Goodwill Impairment Charge
Date:2/26/2009

NATICK, Mass., Feb. 26 /PRNewswire-FirstCall/ -- Boston Scientific Corporation (NYSE: BSX) today announced updated financial results for the fourth quarter ended December 31, 2008. Subsequent to the release of earnings on January 28, the Company accrued for a patent litigation settlement and, as expected, finalized a previously announced goodwill impairment charge. In accordance with U.S. Generally Accepted Accounting Principles, these events are required to be recorded in the fourth quarter as they occurred after the January 28 earnings release and before the filing of the Company's Annual Report on Form 10-K.

The patent litigation settlement resulted in a pre-tax charge of $23 million ($18 million after-tax). The finalization of the goodwill impairment charge reflected a $54 million credit (on both a pre-tax and after-tax basis) and resulted in a final charge of $2.613 billion compared to the previously reported charge of $2.667 billion.

The table below reconciles the Company's updated fourth quarter financial results to those previously reported. The adjustments in the table are also reflected in the Company's Form 10-K, which will be filed tomorrow.

                                        Q4 2008 Results

                                       Goodwill
    In millions, except  Previously   Impairment  Litigation     As
     per share data       Reported   Finalization Settlement  Updated

    Loss before income
     taxes                  $(2,557)          $54       $(23) $(2,526)
    Net loss                $(2,430)          $54       $(18) $(2,394)

    GAAP EPS                 $(1.62)        $0.04     $(0.01)  $(1.59)
    Adjusted EPS              $0.21                   $(0.01)   $0.20


Boston Scientific is a worldwide developer, manufacturer and marketer of medic
'/>"/>

SOURCE Boston Scientific Corporation
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10

Related biology technology :

1. Boston Scientific Announces Japanese Approval for TAXUS(R) Liberte(R) Drug-Eluting Stent System
2. Biotechnology Veteran Michael Webb Joins Boston-based Investment Bank as Senior Advisor
3. Boston Scientific Acquires Labcoat Limited
4. FDA Approves Boston Scientifics Express(R) SD Renal Stent System
5. Kendle to Present at the 2008 Raymond James Boston Fall Investors Conference
6. Boston Scientific to Participate in Piper Jaffray Health Care Conference
7. Trusted LASIK Surgeons Welcomes LASIK Expert Michael Raizman of Boston to its Unique LASIK Directory
8. Idenix Pharmaceuticals to Present at Deutsche Banks 2008 Biotech Boston Confab
9. FDA Approves Boston Scientifics Apex(TM) PTCA Dilatation Catheter
10. InterMune to Present at Deutsche Bank Biotech Boston Confab
11. Boston Healthcare Appoints Adam Barak as Vice President Enhancing Its International Pricing and Reimbursement Capability
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/18/2014)... Ireland , September 18, 2014 ... and Markets ( http://www.researchandmarkets.com/research/czvg3s/biocompatible ) has ... "Biocompatible Materials - Global Strategic Business ... ,     (Logo: http://photos.prnewswire.com/prnh/20130307/600769) ,This report analyzes ... in US$ Million by the following ...
(Date:9/18/2014)... , Sept. 18, 2014 Research ... "Global and Chinese Stem Cell Industry Report, 2014-2017" ... cells are undifferentiated biological cells that can differentiate into ... more stem cells. Stem cell therapy can be applied ... hematological system disease), nervous system diseases, damage or lesion ...
(Date:9/18/2014)... Research and Markets has announced the addition ... In-situ hybridization, Immunohistochemistry) Market - Trends & Forecasts to ... The global companion diagnostics market is expected to grow ... Factors such as rising need for personalized medicine in ... pharmaceutical industry, support from regulatory authorities, and emerging technologies ...
(Date:9/18/2014)...  MEI Pharma, Inc. (Nasdaq: MEIP ), an ... for cancer, announced today that Daniel P. Gold , ... NewsMakers in the Biotech Industry conference on Friday, ... Millennium Broadway Hotel & Conference Center in New ... be accessed at www.meipharma.com . A replay will be ...
Breaking Biology Technology:Biocompatible Materials - Global Strategic Business Report 2014 2Biocompatible Materials - Global Strategic Business Report 2014 3Global and Chinese Stem Cell Industry Report, 2014-2017 2Global and Chinese Stem Cell Industry Report, 2014-2017 3Global Companion Diagnostics (Polymerase Chain Reaction, In-situ hybridization, Immunohistochemistry) Market - Trends & Forecasts to 2019 2Global Companion Diagnostics (Polymerase Chain Reaction, In-situ hybridization, Immunohistochemistry) Market - Trends & Forecasts to 2019 3MEI Pharma To Present At BioCentury's NewsMakers Conference 2MEI Pharma To Present At BioCentury's NewsMakers Conference 3
... Amnis Corporation, a manufacturer of advanced cell imaging systems, ... Millipore, the Life Science division of Merck KGaA of Germany. ... expected to take place in the fourth quarter of 2011. ... Amnis generated sales of USD 14 million (EUR 10 ...
... infect cells is crucial to preventing countless human diseases. ... Bristol have discovered a new approach for studying molecules ... the complexity of how bacteria infect people. The ... physicists and published in the Proceedings of the ...
... 2011 /PRNewswire-Asia-FirstCall/ -- China Cord Blood Corporation (NYSE: ... cord blood collection, laboratory testing, hematopoietic stem cell processing, and ... results for the first quarter of fiscal year 2012, which ... Quarter of Fiscal 2012Highlights ...
Cached Biology Technology:Amnis Acquired by EMD Millipore - Expands Growth Potential 2Amnis Acquired by EMD Millipore - Expands Growth Potential 3Scientists develop new technologies for understanding bacterial infections 2Scientists develop new technologies for understanding bacterial infections 3China Cord Blood Corporation Reports Financial Results for the First Quarter of Fiscal 2012 2China Cord Blood Corporation Reports Financial Results for the First Quarter of Fiscal 2012 3China Cord Blood Corporation Reports Financial Results for the First Quarter of Fiscal 2012 4China Cord Blood Corporation Reports Financial Results for the First Quarter of Fiscal 2012 5China Cord Blood Corporation Reports Financial Results for the First Quarter of Fiscal 2012 6China Cord Blood Corporation Reports Financial Results for the First Quarter of Fiscal 2012 7China Cord Blood Corporation Reports Financial Results for the First Quarter of Fiscal 2012 8China Cord Blood Corporation Reports Financial Results for the First Quarter of Fiscal 2012 9China Cord Blood Corporation Reports Financial Results for the First Quarter of Fiscal 2012 10
(Date:9/18/2014)... system that can operate inside the bore of an ... a biomedical research partnership program at Brigham and Women,s ... the robot, in conjunction with real-time MRI images, can ... and less discomforting for the patient. The novel system ... with greater precision. , Developed by a team of ...
(Date:9/18/2014)... the International Space Station ever starts a "frequent flyers" ... status. Recently the orbiting laboratory has hosted increasing numbers ... returned from the space station in April, and another ... third experiment is planned to launch in December. , ... around the world-- and in space. Model organisms can ...
(Date:9/18/2014)... that prompts millions of Americans to undertake jaunts into the ... a little longer within a century, according to new research. ... areas of the United States as summer temperatures linger later ... Global Ecology and Biogeography . For instance, the paper ... tree of New Hampshire could change color one to ...
Breaking Biology News(10 mins):Trial begins for MRI-compatible robot designed to improve accuracy of prostate biopsies 2Trial begins for MRI-compatible robot designed to improve accuracy of prostate biopsies 3Trial begins for MRI-compatible robot designed to improve accuracy of prostate biopsies 4Trial begins for MRI-compatible robot designed to improve accuracy of prostate biopsies 5Buzzing with activity: Fruit flies orbit Earth for science 2Buzzing with activity: Fruit flies orbit Earth for science 3Buzzing with activity: Fruit flies orbit Earth for science 4Fall foliage season may be later, but longer on warmer Earth 2Fall foliage season may be later, but longer on warmer Earth 3Fall foliage season may be later, but longer on warmer Earth 4
... generation of "green" automobile tires that can boost fuel efficiency ... the research pipeline. The new tires could help add an ... economy. That,s the topic of the cover story of the ... newsmagazine. C&EN Senior Editor Alexander Tullo explains that ...
... causing fatal and infectious diseases of the nervous system, ... sheep or Creutzfeldt-Jakob disease in humans. Scientists of Helmholtz ... in elucidating another disease mechanism of prion diseases: The ... quantities of cholesterol. Prions need this for their propagation. ...
... Rochelle, NY, November 18, 2009Quantitative polymerase chain reaction ... and rapid expansion as a result of advances ... wells and optimization-free multiplexing, reports Genetic Engineering & ... detect and simultaneously quantify specific DNA sequences is ...
Cached Biology News:The protein Srebp2 drives cholesterol formation in prion-infected neuronal cells 2
ANTI 5-HYDROXYTRYPTOPHAN CONJ....
IMAGEQUANT 300 WKSTN, 1 EA. Category: ImageQuant CCD Imagers....
... use with T4 Polynucleotide Kinase for ... ends) of nucleic acids. In the ... the 5' phosphate group from DNA ... Gamma-phosphate of ATP to the free ...
JTV1 gene...
Biology Products: